COM_RESEARCHSTUDIES_DETAIL_AVAL_STATUS_4

Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

This is a study for people with colon, pancreatic, Squamous Non-small cell lung cancer, or Squamous cell carcinoma of head and neck. In this study, we want to find out if an investigational drug (Tisotumab Vedotin) is effective for people with solid tumors.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Shetal Patel
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Phase 1 Trials (all cancers))

IRB Number

19-0031

ClinicalTrials.gov

NCT03175224

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.